CSBR:NASDAQ
Champions Oncology Inc
4,45 USD
arrow_upward
+1,14%(+0,050) 1 D
20. nov., 09:59:27 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,45 USD
Markedsverdi
61,94 mill.
Snittvolum
6,97k
Volum
4,96k
52 u høy
8,31 USD
52 u lav
4,40 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,45 USD
Markedsverdi
61,94 mill.
Snittvolum
6,97k
Volum
4,96k
52 u høy
8,31 USD
52 u lav
4,40 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
Nacionale
·
for 34 minutter siden
Why is the S&P 500 down today? AI sell-off puts it on track for a seventh straight loss
ChartMill
·
for 3 timer siden
S&P 500 Premarket Movers Friday: Gainers and Losers
Traders Union
·
for 3 timer siden
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
www.tokenpost.com
·
for 17 minutter siden
BTIG Sees S&P 500 Near Tactical Bottom as Breadth Points to More Downside
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com